Accessibility Menu
Adia Nutrition logo

Adia Nutrition(OTC) ADIA

Current Price$0.16
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)+0%
5 Year+4,167%
1 Year+325%
1 Month+22%
Adia Nutrition last closing stock price
MetricPriceDate
Last closeUSD 0.162026-07-24
Adia Nutrition stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+39.13%USD 0.122026-07-17
1 month+22.14%USD 0.132026-06-23
3 month-15.34%USD 0.192026-04-24
Year to date+105.13%USD 0.082025-12-30
1 year+324.97%USD 0.042025-07-24
3 year+945.75%USD 0.022023-07-25
5 year+4,166.67%USD 0.002021-07-22
Since inception+0%USD 0.162004-03-23

Adia Nutrition Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$0.16

Volume

33,857

Open

$0.11

Previous Close

$0.16

Daily Range

$0.11 - $0.16

52-Week Range

$0.02 - $0.28

Estimated Earnings Date

N/A

ADIA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adia Nutrition

Adia Nutrition offers stem cell therapies and biologic products for people with chronic health conditions. Its clinics provide treatments for pain, tissue repair, and age-related issues. The company also sells supplements and related products to consumers and clinics.

What’s on the Menu? Adia’s Core Offerings

  • Biologic Products (63.3%): Stem cell and exosome products for clinics and research, targeting tissue repair and chronic conditions.
  • Medical Procedures (35.1%): In-clinic stem cell therapies for pain management, wound healing, and anti-aging, serving patients directly.
  • Supplements (0.5%): Protein coffee and wellness supplements, sold online and through partners, aimed at health-conscious consumers.
  • Ancillary Products (0.1%): Additional health-related items supporting core therapies, sold to clinics and patients.
  • Shipping & Services (1.0%): Delivery and support services for products and procedures, ensuring access for end users.

Growth Spurts: Adia’s Expansion Story

  • Acquired Biolete, LLC in 2024; sold it to Cement Factory, LLC in 2025.
  • Invested in Cement Factory, LLC (18% equity) in 2025 to maintain supplement market exposure.
  • Launched Adia Med clinic and Adia Labs biologics supply in 2025, expanding medical and product offerings.
  • Rolled out new stem cell and exosome products (AdiaVita, AdiaLink) in 2025.
  • Expanded clinic network nationwide in 2025, focusing on regenerative therapies.

Why Adia’s Not Just Another Face in the Crowd

Adia combines medical clinics with a biologics supply chain, offering both direct care and product sales. Its products meet U.S. regulatory standards and are produced in accredited labs. The company’s integrated approach supports both patient treatment and business-to-business sales.

Five Things You Need to Know

  • Revenue was $700,508 in 2025, up 10,882% from 2024.
  • Biologic products made up 63.3% of 2025 revenue; medical procedures 35.1%.
  • Net loss was $(395,464) in 2025, widening from $(181,067) in 2024.
  • Gross margin was 27.4% in 2025, with all sales in the U.S.
  • Auditor raised going concern warning due to recurring losses and cash flow issues in 2025.

Bottom Line

Adia has shifted from supplements to focus on stem cell therapies and biologics. The company’s integrated model and recent expansion reflect ongoing adaptation in a challenging market.

AI Generated • Apr 16, 2026

Industry

Personal Products

Sector

Consumer Staples

Headquarters

Winter Park, FL 96760, US

ADIA Financials

Key Financial Metrics (TTM)

Gross Margin

27.36%

Operating Margin

-52.32%

Net Income Margin

-56.45%

Return on Equity

306.95%

Return on Capital

-107.06%

Return on Assets

-66.48%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

33.86K

Avg. Volume

12.75K

Financials (TTM)

Gross Profit

$66.57K

Operating Income

-$151.92K

EBITDA

-$144.87K

Operating Cash Flow

-$55.04K

Capital Expenditure

$0.00

Free Cash Flow

-$55.04K

Cash & ST Invst.

$136.72K

Total Debt

$902.10K

Adia Nutrition Performance Analysis

Adia Nutrition sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-12-31N/A
Q12026-03-31N/A
Adia Nutrition sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-12-31N/A
Q12026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$176.28K

N/A

Gross Profit

$66.57K

N/A

Gross Margin

37.76%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

3

N/A

Net Income

-$162.53K

N/A

EBITDA

-$144.87K

N/A

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$136.72K

N/A

Total Debt

$902.10K

N/A

Accounts Receivable

$79.36K

N/A

Inventory

$72.11K

N/A

Long Term Debt

$87.40K

N/A

Short Term Debt

$814.71K

N/A

Return on Assets

-66.48%

N/A

Return on Invested Capital

-81.51%

N/A

Free Cash Flow

-$55.04K

N/A

Operating Cash Flow

-$55.04K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MVCOMetavesco, Inc.
$0.00+0.00%
AVVHAVVAA World Health Care Products, Inc.
$0.00+0.00%
LZGILZG International, Inc.
$0.00+0.00%
ETEREnterra Corporation
$0.03+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About ADIA

What is the current price of Adia Nutrition?

Adia Nutrition is trading at $0.16 per share.

What is the 52-week range for Adia Nutrition?

Over the past 52 weeks, Adia Nutrition has traded between $0.02 and $0.28.

How much debt does Adia Nutrition have?

Adia Nutrition total debt is unavailable.

How much cash does Adia Nutrition have on hand?

Adia Nutrition does not have cash on hand data available.

What is Adia Nutrition’s dividend yield?

Adia Nutrition does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services